June 25 | 2020 2cureX receives third payment from the EU’ Horizon 2020 SME- Instrument Program Read more
June 16 | 2020 2cureX AB establishes collaboration with Scandion Oncology A/S and Erasmus Medical Centre, Rotterdam, in drug-resistant breast cancer patients Read more
May 29 | 2020 2cureX moves forward with the commercialization of IndiTreat by signing a new distributor agreement in Portugal Read more
April 29 | 2020 2cureX German subsidiary receives a grant contribution to support the activities towards automation of the IndiTreat® test Read more
April 6 | 2020 2cureX i Tyskland får bidrag för att anpassa IndiTreat® för vägledning av immunterapi mot äggstockscancer Read more
March 23 | 2020 2cureX provides update regarding the COVID-19 impact on ongoing clinical programs Read more
March 12 | 2020 Försiktighetsåtgärder med anledning av COVID-19: Insatser på distans säkrar fortsatt screening av prov till stöd för cancerpatienter Read more
March 6 | 2020 2cureX ökar takten i kommersialiseringen av IndiTreat® – tecknar två nya distributörsavtal inför lansering andra halvan av 2020 Read more